These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
548 related articles for article (PubMed ID: 10797308)
21. Epidermal growth factor receptor in cultured human retinal pigment epithelial cells. Yan F; Hui YN; Li YJ; Guo CM; Meng H Ophthalmologica; 2007; 221(4):244-50. PubMed ID: 17579290 [TBL] [Abstract][Full Text] [Related]
22. EGFR-independent activation of ERK1/2 mediates growth inhibition by a PTPase antagonizing K-vitamin analog. Kar S; Adachi T; Carr BI J Cell Physiol; 2002 Mar; 190(3):356-64. PubMed ID: 11857451 [TBL] [Abstract][Full Text] [Related]
23. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor. Nicholl SM; Roztocil E; Davies MG J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933 [TBL] [Abstract][Full Text] [Related]
24. Mechanisms for prostaglandin E2 formation caused by proteinase-activated receptor-1 activation in rat gastric mucosal epithelial cells. Sekiguchi F; Saito S; Takaoka K; Hayashi H; Nagataki M; Nagasawa K; Nishikawa H; Matsui H; Kawabata A Biochem Pharmacol; 2007 Jan; 73(1):103-14. PubMed ID: 17069767 [TBL] [Abstract][Full Text] [Related]
25. Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA. Li J; Ma C; Huang Y; Luo J; Huang C Oncogene; 2003 Jan; 22(2):211-9. PubMed ID: 12527890 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of rat liver regeneration after partial hepatectomy and induction of ERK phosphorylation by Cpd 5, a K vitamin-based anticancer compound. Kar S; Wang M; Rosi KS; Wilcox CS; Carr BI Carcinogenesis; 2004 Dec; 25(12):2345-51. PubMed ID: 15319298 [TBL] [Abstract][Full Text] [Related]
27. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells. Johnson FM; Saigal B; Donato NJ J Cell Physiol; 2005 Nov; 205(2):218-27. PubMed ID: 15887238 [TBL] [Abstract][Full Text] [Related]
28. Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways. Huang L; Watanabe M; Chikamori M; Kido Y; Yamamoto T; Shibuya M; Gotoh N; Tsuchida N Oncogene; 2006 Oct; 25(49):6457-66. PubMed ID: 16702953 [TBL] [Abstract][Full Text] [Related]
29. Specific inhibition of FGF-induced MAPK activation by the receptor-like protein tyrosine phosphatase LAR. Wang X; Weng LP; Yu Q Oncogene; 2000 May; 19(19):2346-53. PubMed ID: 10822386 [TBL] [Abstract][Full Text] [Related]
30. Skin cancer chemopreventive effects of a flavonoid antioxidant silymarin are mediated via impairment of receptor tyrosine kinase signaling and perturbation in cell cycle progression. Ahmad N; Gali H; Javed S; Agarwal R Biochem Biophys Res Commun; 1998 Jun; 247(2):294-301. PubMed ID: 9642119 [TBL] [Abstract][Full Text] [Related]
31. EGF-dependent and independent programmed cell death pathways in NCI-H596 nonsmall cell lung cancer cells. Lei W; Mayotte JE; Levitt ML Biochem Biophys Res Commun; 1998 Apr; 245(3):939-45. PubMed ID: 9588219 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation. Lipson KE; Pang L; Huber LJ; Chen H; Tsai JM; Hirth P; Gazit A; Levitzki A; McMahon G J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635 [TBL] [Abstract][Full Text] [Related]
33. Response to transforming growth factor alpha (TGFalpha) and epidermal growth factor (EGF) in hepatocytes: lower EGF receptor affinity of TGFalpha is associated with more sustained activation of p42/p44 mitogen-activated protein kinase and greater efficacy in stimulation of DNA synthesis. Thoresen GH; Guren TK; Sandnes D; Peak M; Agius L; Christoffersen T J Cell Physiol; 1998 Apr; 175(1):10-8. PubMed ID: 9491776 [TBL] [Abstract][Full Text] [Related]
34. A comparative study of the hepatic mitogen-activated protein kinase and Jun-NH2-terminal kinase pathways in the late-gestation fetal rat. Boylan JM; Gruppuso PA Cell Growth Differ; 1996 Sep; 7(9):1261-9. PubMed ID: 8877106 [TBL] [Abstract][Full Text] [Related]
35. Activation and glucagon regulation of mitogen-activated protein kinases (MAPK) by insulin and epidermal growth factor in cultured rat and human hepatocytes. Ulrich RG; Cramer CT; Adams LA; Kletzien RF Cell Biochem Funct; 1998 Jun; 16(2):77-85. PubMed ID: 9636995 [TBL] [Abstract][Full Text] [Related]
36. Hydrogen peroxide induces complex formation of SHC-Grb2-SOS with receptor tyrosine kinase and activates Ras and extracellular signal-regulated protein kinases group of mitogen-activated protein kinases. Rao GN Oncogene; 1996 Aug; 13(4):713-9. PubMed ID: 8761292 [TBL] [Abstract][Full Text] [Related]
37. Modulation of hepatic acute phase gene expression by epidermal growth factor and Src protein tyrosine kinases in murine and human hepatic cells. Wang Y; Ripperger J; Fey GH; Samols D; Kordula T; Wetzler M; Van Etten RA; Baumann H Hepatology; 1999 Sep; 30(3):682-97. PubMed ID: 10462375 [TBL] [Abstract][Full Text] [Related]
38. Role of Shc in the activation of Ras in response to epidermal growth factor and nerve growth factor. Basu T; Warne PH; Downward J Oncogene; 1994 Dec; 9(12):3483-91. PubMed ID: 7970708 [TBL] [Abstract][Full Text] [Related]
39. Potent SHC tyrosine phosphorylation by epidermal growth factor at low receptor density or in the absence of receptor autophosphorylation sites. Soler C; Alvarez CV; Beguinot L; Carpenter G Oncogene; 1994 Aug; 9(8):2207-15. PubMed ID: 8036006 [TBL] [Abstract][Full Text] [Related]
40. Characterization of epidermal growth factor receptor function in lysophosphatidic acid signaling in PC12 cells. Kim SN; Park JG; Lee EB; Kim SS; Yoo YS J Cell Biochem; 2000 Jan; 76(3):386-93. PubMed ID: 10649436 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]